SPP1 and age-related macular degeneration: In murine models of subretinal inflammation and AMD, SPP1 deletion or pharmacological inhibition reversed HTRA1-induced pathogenic persistence of mononuclear phagocytes in the subretinal space thus paving the way for SPP1 inhibitors for the treatment of AMD (50).